Related Experiment Videos
Expression of SV40 T antigen during inhibition of DNA synthesis
Cancer Letters
|March 1, 1976
Abstract:
Treatment of human SV40-transformed cells with excess thymidine or cytosine arabinoside caused a rapid decrease in the expression of T antigen as determined by quantitative immunofluorimetry.
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
T-cell receptor clonotype mapping using denaturing gradient gel electrophoresis : analysis of clonal T-cell responses in melanoma.
Methods in molecular medicine·2012
Kinetics and function of peritoneal-exudate cells during local IL-2 gene-therapy of cancer.
International journal of oncology·2011
T-cell receptor v-alpha and v-Beta gene usage in interleukin-2-cultured tumor-infiltrating lymphocytes from patients with breast-cancer.
International journal of oncology·2011
Genetically modified tumour vaccines.
International journal of oncology·2011
Live probiotic Bifidobacterium lactis bacteria inhibit the toxic effects induced by wheat gliadin in epithelial cell culture.
Clinical and experimental immunology·2008
Multiple mechanisms of immune evasion can coexist in melanoma tumor cell lines derived from the same patient.
Cancer immunology, immunotherapy : CII·2001
Ni-Loaded SnO2-MoS2 Heterostructure for Highly Selective and Low-Temperature SO2 Sensing With Real-Time Device Integration.
Small (Weinheim an der Bergstrasse, Germany)·2026
Plasmonic Foam-Enabled Dual-Modal Biohybrid Chemical Sensor.
Advanced materials (Deerfield Beach, Fla.)·2026
Plasmon-enhanced molecularly imprinted photoelectrochemical sensor for non-invasive lactate monitoring in sweat.
Chemical communications (Cambridge, England)·2026
Structural insights into target detection by the Serratia type III CRISPR complex and its deployment in SNP identification.
The Journal of biological chemistry·2026
Cefalexin fingerprinting in water using graphene oxide/gold nanoparticle-modified silica photonic microsphere SERS substrates.
Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy·2026